Overexpression of estrogen receptor beta and its prognostic significance among malignant pleural mesothelioma patients

被引:0
|
作者
Helali, Mariam [1 ,3 ]
Abdelmotal, Ahmed [1 ]
Gobran, Nagy [1 ]
El Ghazaly, Hesham [1 ]
El Mahdy, Manal [2 ]
Karim, Khaled [1 ]
机构
[1] Ain Shams Univ, Fac Med, Clin Oncol Dept, Cairo, Egypt
[2] Ain Shams Univ, Fac Med, Pathol Dept, Cairo, Egypt
[3] 38 Abbassia,Next Al Nour Mosque, Cairo, Egypt
来源
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS | 2024年 / 73卷 / 01期
关键词
mesothelioma; ER beta; prognostic; biomarkers; HEALTH;
D O I
10.4103/ecdt.ecdt_25_23
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background The overexpression of estrogen receptor beta (ER beta) and its correlation with prognosis of malignant mesothelioma remains controversial and unexplored. This study aimed at studying ER beta expression in tumour tissue in patients with pleural mesothelioma and its association with clinical and pathological factors and survival analysis. Material and methods A prospective cohort study was conducted on patients who were diagnosed with malignant pleural mesothelioma (MPM) in Ain Shams university hospitals, the primary end point was to correlate ER beta overexpression that was analysed by immunohistochemistry (IHC) on paraffin tissue blocks with 1-year overall survival (OS) among MPM patients, the secondary endpoint was to correlate ER beta overexpression with 1-year progression free survival (PFS) and response to platinum-based chemotherapy among MPM patients. Results A total 42 MPM patients were included, High ER beta expression (modified Allred score 7-9) was reported in 9.5% of the patients (4 cases), moderate expression (modified Allred score 4-6) was reported in 28.6% of the patients(12 cases), weak and negative expression ( modified Allred score 0-3) was reported in 61% of the patients(26 cases), percent of ER beta positive cases was 69% of the total patients, there was no statistical difference as regard age (p value:0.8), sex(p value:0.4), stage (p value: 0.71), ECOG (p value :0.84) , histological subtype(p value:0.17) and response to platinum based treatment (p value:0.5) across the 3 groups of patients (high, moderate , weak and negative ER beta on tumour tissues) there was no statistically significant difference in OS and PFS for ER beta overexpression. Conclusion The overexpression of ER beta was not associated with improved OS or PFS in mesothelioma patients, despite high rate of ER beta positive cases in our analysis, larger sample size would be recommended for more solid conclusions
引用
收藏
页码:85 / 90
页数:6
相关论文
共 50 条
  • [31] Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma
    Fujimoto, Nobukazu
    Gemba, Kenichi
    Asano, Michiko
    Fuchimoto, Yasuko
    Wada, Sae
    Ono, Katsuichiro
    Ozaki, Shinji
    Kishimoto, Takumi
    RESPIRATORY INVESTIGATION, 2013, 51 (02) : 92 - 97
  • [32] Prognostic value of FDG PET imaging in malignant pleural mesothelioma
    Bénard, F
    Sterman, D
    Smith, RJ
    Kaiser, LR
    Albelda, SM
    Alavi, A
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (08) : 1241 - 1245
  • [33] Surgically debulked malignant pleural mesothelioma: Results and prognostic factors
    Harvey I. Pass
    Karen Kranda
    Barbara K. Temeck
    Irwin Feuerstein
    Seth M. Steinberg
    Annals of Surgical Oncology, 1997, 4 : 215 - 222
  • [34] Dysphagia in Patients with Malignant Pleural Mesothelioma (MPM)
    Malec, M.
    Desai, A.
    Waxman, I.
    Karrison, T.
    Rose, B.
    Mendoza, A.
    Gadiraju, M.
    Straus, C.
    Churpek, J.
    Kindler, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S759 - S760
  • [35] Surgically debulked malignant pleural mesothelioma: Results and prognostic factors
    Pass, HI
    Kranda, K
    Temeck, BK
    Feuerstein, I
    Steinberg, SM
    ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (03) : 215 - 222
  • [36] Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma
    Nakano, T
    Chahinian, AP
    Shinjo, M
    Tonomura, A
    Miyake, M
    Togawa, N
    Ninomiya, K
    Higashino, K
    BRITISH JOURNAL OF CANCER, 1998, 77 (06) : 907 - 912
  • [37] Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma
    Beatrice Dozin
    Grazia Carbotti
    Silvio Roncella
    Paola Ferro
    Paolo Dessanti
    Pier Aldo Canessa
    Silvano Ferrini
    Marina Fabbi
    Cancer Immunology, Immunotherapy, 2021, 70 : 3349 - 3355
  • [38] Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma
    Stockhammer, Paul
    Ploenes, Till
    Theegarten, Dirk
    Schuler, Martin
    Maier, Sandra
    Aigner, Clemens
    Hegedus, Balazs
    LUNG CANCER, 2020, 139 : 124 - 132
  • [39] Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma
    Dozin, Beatrice
    Carbotti, Grazia
    Roncella, Silvio
    Ferro, Paola
    Dessanti, Paolo
    Canessa, Pier Aldo
    Ferrini, Silvano
    Fabbi, Marina
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (11) : 3349 - 3355
  • [40] Predictive and Prognostic Value of Clinical TNM Staging for Patients with Malignant Pleural Mesothelioma Undergoing Surgery
    Gill, Ritu R.
    Bueno, Raphael
    Richards, William
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S224 - S224